Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants
Clinical trial NCT06007781 · COMPLETED
Trial details
- NCT number
- NCT06007781
- Sponsor
- HilleVax
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2024-05-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.